AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇿🇼

PALBOCICLIB in Zimbabwe

9 products registered with MCAZ 9 active

Brand / ProductReg. No.HolderStatusExpires
PALBOCICLIB PFIZER
TABLET, COATED; ORAL
2023/9.5.2/6499PFIZER LABORATORIES (PTY) LTD, S.Aactive2 Nov 2028
PALBOCILIB PFIZER
TABLET, COATED; ORAL
2023/9.5.2/6500PFIZER LABORATORIES (PTY) LTD, S.Aactive2 Nov 2028
IBRANCE
TABLET, COATED; ORAL
2023/9.5.2/6504PFIZER LABORATORIES (PTY) LTDactive2 Nov 2028
IBRANCE
TABLET, COATED; ORAL
2023/9.5.2/6502PFIZER LABORATORIES (PTY) LTDactive2 Nov 2028
IBRANCE
TABLET, COATED; ORAL
2023/9.5.2/6503PFIZER LABORATORIES (PTY) LTDactive2 Nov 2028
PALBOCICLIB PFIZER
TABLET, COATED; ORAL
2023/9.5.2/6501PFIZER LABORATORIES (PTY) LTDactive2 Nov 2028
PALBOCICLIB PFIZER
CAPSULE; ORAL
2017/9.5.2/5507PFIZER LABORATORIES (PTY) LTDactive31 Dec 2027
PALBOCICLIB PFIZER
CAPSULE; ORAL
2017/9.7/5506PFIZER LABORATORIES (PTY) LTD, S.Aactive31 Dec 2027
PALBOCICLIB PFIZER
CAPSULE; ORAL
2017/9.5.2/5505PFIZER LABORATORIES (PTY) LTDactive31 Dec 2027

PALBOCICLIBMCAZ Registration Details

MCAZ (Zimbabwe) has 9 registered products containing PALBOCICLIB, of which 9 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.

Track PALBOCICLIB registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.